The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027
The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
The campaign places renewed focus on a disease that remains incurable despite major scientific advances
Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness
Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
